Cargando…

Randomised Controlled Trial of Nutritional Supplement on Bone Turnover Markers in Indian Premenopausal Women

Young Indian women may be at risk of poor bone health due to malnutrition. The aim of this study was to examine the effects on bone metabolism of a nutritional supplement in women aged 25 to 44. The nutritional supplement was a protein-rich beverage powder fortified with multi-micronutrients includi...

Descripción completa

Detalles Bibliográficos
Autores principales: Umarji, Pramod B., Verma, Pankaj, Garg, Vivek, Schini, Marian, Eastell, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912479/
https://www.ncbi.nlm.nih.gov/pubmed/33530298
http://dx.doi.org/10.3390/nu13020364
_version_ 1783656586314514432
author Umarji, Pramod B.
Verma, Pankaj
Garg, Vivek
Schini, Marian
Eastell, Richard
author_facet Umarji, Pramod B.
Verma, Pankaj
Garg, Vivek
Schini, Marian
Eastell, Richard
author_sort Umarji, Pramod B.
collection PubMed
description Young Indian women may be at risk of poor bone health due to malnutrition. The aim of this study was to examine the effects on bone metabolism of a nutritional supplement in women aged 25 to 44. The nutritional supplement was a protein-rich beverage powder fortified with multi-micronutrients including calcium (600 mg), vitamin D (400 IU), and vitamin K (55 mcg) per daily serving, while a placebo supplement was low-protein non-fortified isocaloric beverage powder. This 6-month randomised, controlled trial showed favorable changes in bone turnover markers (decreased) and calcium homeostasis; such changes in older adults have been associated with slowing of bone loss and reduced fracture risk. For example, serum CTX decreased by about 30% and PINP by about 20% as a result of the increase in calcium intake. There were also changes in the ratio of carboxylated to undercarboxylated osteocalcin and such changes have been linked to a slowing of bone loss in older subjects. For example, the ratio increased by about 60% after 3 months as a result in the improvement in vitamin K status. Finally, there were improvements in the status of B vitamins, and such changes have been associated with reductions in homocysteine, but it is uncertain whether this would affect fracture risk. The product was generally well tolerated. This study shows the nutritional supplement holds promise for improved bone health among young Indian women.
format Online
Article
Text
id pubmed-7912479
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79124792021-02-28 Randomised Controlled Trial of Nutritional Supplement on Bone Turnover Markers in Indian Premenopausal Women Umarji, Pramod B. Verma, Pankaj Garg, Vivek Schini, Marian Eastell, Richard Nutrients Article Young Indian women may be at risk of poor bone health due to malnutrition. The aim of this study was to examine the effects on bone metabolism of a nutritional supplement in women aged 25 to 44. The nutritional supplement was a protein-rich beverage powder fortified with multi-micronutrients including calcium (600 mg), vitamin D (400 IU), and vitamin K (55 mcg) per daily serving, while a placebo supplement was low-protein non-fortified isocaloric beverage powder. This 6-month randomised, controlled trial showed favorable changes in bone turnover markers (decreased) and calcium homeostasis; such changes in older adults have been associated with slowing of bone loss and reduced fracture risk. For example, serum CTX decreased by about 30% and PINP by about 20% as a result of the increase in calcium intake. There were also changes in the ratio of carboxylated to undercarboxylated osteocalcin and such changes have been linked to a slowing of bone loss in older subjects. For example, the ratio increased by about 60% after 3 months as a result in the improvement in vitamin K status. Finally, there were improvements in the status of B vitamins, and such changes have been associated with reductions in homocysteine, but it is uncertain whether this would affect fracture risk. The product was generally well tolerated. This study shows the nutritional supplement holds promise for improved bone health among young Indian women. MDPI 2021-01-26 /pmc/articles/PMC7912479/ /pubmed/33530298 http://dx.doi.org/10.3390/nu13020364 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Umarji, Pramod B.
Verma, Pankaj
Garg, Vivek
Schini, Marian
Eastell, Richard
Randomised Controlled Trial of Nutritional Supplement on Bone Turnover Markers in Indian Premenopausal Women
title Randomised Controlled Trial of Nutritional Supplement on Bone Turnover Markers in Indian Premenopausal Women
title_full Randomised Controlled Trial of Nutritional Supplement on Bone Turnover Markers in Indian Premenopausal Women
title_fullStr Randomised Controlled Trial of Nutritional Supplement on Bone Turnover Markers in Indian Premenopausal Women
title_full_unstemmed Randomised Controlled Trial of Nutritional Supplement on Bone Turnover Markers in Indian Premenopausal Women
title_short Randomised Controlled Trial of Nutritional Supplement on Bone Turnover Markers in Indian Premenopausal Women
title_sort randomised controlled trial of nutritional supplement on bone turnover markers in indian premenopausal women
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912479/
https://www.ncbi.nlm.nih.gov/pubmed/33530298
http://dx.doi.org/10.3390/nu13020364
work_keys_str_mv AT umarjipramodb randomisedcontrolledtrialofnutritionalsupplementonboneturnovermarkersinindianpremenopausalwomen
AT vermapankaj randomisedcontrolledtrialofnutritionalsupplementonboneturnovermarkersinindianpremenopausalwomen
AT gargvivek randomisedcontrolledtrialofnutritionalsupplementonboneturnovermarkersinindianpremenopausalwomen
AT schinimarian randomisedcontrolledtrialofnutritionalsupplementonboneturnovermarkersinindianpremenopausalwomen
AT eastellrichard randomisedcontrolledtrialofnutritionalsupplementonboneturnovermarkersinindianpremenopausalwomen